Live
- Awareness Program on the Harmful Effects of Tobacco Products
- Delhi govt re-launched senior citizen pension scheme despite challenges: Bharadwaj
- Bihar Assembly's winter session begins, three newly elected MLAs take oath
- Inflation to ease, economic growth to accelerate in coming months: Finance Ministry
- Protesters clash with police in J&K’s Katra town
- Senior Bengaluru Police Officer Accused in Suicide of Businesswoman S Jeeva
- Sidhu makes U-turn, says wife underwent cancer treatment along with Ayurveda-based diet
- Demand for entry-level talent surges 59 pc in India’s tech sector
- AIIMS adds 2 new MRI machines to provide more efficient & timely radiology diagnosis
- Ram Gopal Varma evades police questioning
Serum Institute pauses Coronavirus vaccine trials
Serum Institute pauses Coronavirus vaccine trials
The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University, on Thursday paused the clinical trials of the vaccine in India.
New Delhi: The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University, on Thursday paused the clinical trials of the vaccine in India.
In a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and will not be able to comment further on trials." The declaration by the Pune-based vaccine manufacturer came a day after the Drug Control General of India (DCGI), VG Somani, issued a show-cause notice to them asking for an explanation as to why the institute decided to go ahead with the clinical trial of Covid-19 vaccine candidate while doubts about patient safety are yet unclear.
